drugset / Trial / NCT00994994

Tranexamic Acid in Pediatric Cardiac Surgery

NCT00994994

Completed 160 enrolled Okayama University
RandomizedParallel-groupSingle-blindTreatment

Summary

Tranexamic acid(TXA) is an antifibrinolytic agent to reduce blood loss in cardiac surgery. Previous seven RCTs comparing effects of TXA in pediatric cardiac surgery showed conflict results. The reason why they showed mixed results would be the imbalance of patients population with regard to presence of cyanosis. TXA would reduce blood loss in pediatric cardiac surgery with well balanced patients population.

Timeline

Start
2006-01
Primary completion
2007-08
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 15 mg/kg